Patent Expiry
VSTM: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED): recorded patent 11873296 expiry
December 29, 2042 · AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 29, 2042
- Company
- Verastem, Inc. (VSTM)
- Drug
- AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
AVMAPKI FAKZYNJA CO-PACK (COPACKAGED): recorded patent 11873296 expiry
Orange Book application NDA219616, product 001, listed patent 11873296 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- Verastem, Inc. (VSTM)
- Drug
- AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE